As DPP-4 is involved in a broad range of biological processes, including hematopoietic cytokine activity and T-cell immune function, it could serve as the basis of a CNI-free cocktail that attacks donor T-cell activation on multiple fronts to more effectively suppress GVHD without harsh CNI side effects. This evidence concerns the gene DPP4 and graft versus host disease.